Viewing Study NCT06891157


Ignite Creation Date: 2025-12-24 @ 6:33 PM
Ignite Modification Date: 2026-01-22 @ 4:26 AM
Study NCT ID: NCT06891157
Status: RECRUITING
Last Update Posted: 2025-03-24
First Post: 2025-03-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chidamide View
None R-CHOP Chemotherapy View
None DLBCL - Diffuse Large B Cell Lymphoma View
None Double-expressor Lymphoma (DEL) View
Keywords: